Liminatus Pharma LIMN
NASDAQ LIMN
$3.75 +0.00 (+0.00%)
As of: Oct 2, 2026 · 9:30 AM EDT

Liminatus Pharma (LIMN) Accumulated Expenses (2024 - 2025)

Updated

Liminatus Pharma's Accumulated Expenses came in at $1,060 for Q1 2025, up 31.7% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Accumulated Expenses (2024 - 2025) Analysis & Trends

At the end of FY2024, Liminatus Pharma's Accumulated Expenses was $805.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Liminatus Pharma 4.18 Mn 4.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1,060.00
Dec 31, 2024 805.00
API Access

Liminatus Pharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LIMN&period=max&api_key=YOUR_API_KEY